ArticleAmerican journal of cancer research2025

Itaconate targets the ERK2 signal to suppress estrogen receptor-positive breast cancer cell growth.

Hsueh-Chun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.